They are a leading T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases.
Last Closing Price
January 4, 2018
To view the prospectus for , or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277